These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8596025)

  • 1. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells.
    Mueller DL; Seiffert S; Fang W; Behrens TW
    J Immunol; 1996 Mar; 156(5):1764-71. PubMed ID: 8596025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
    Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M
    Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients.
    Schirmer M; Vallejo AN; Weyand CM; Goronzy JJ
    J Immunol; 1998 Jul; 161(2):1018-25. PubMed ID: 9670983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2.
    Mor F; Cohen IR
    J Immunol; 1996 Jan; 156(2):515-22. PubMed ID: 8543801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
    Radvanyi LG; Shi Y; Vaziri H; Sharma A; Dhala R; Mills GB; Miller RG
    J Immunol; 1996 Mar; 156(5):1788-98. PubMed ID: 8596028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression.
    Borthwick NJ; Bofill M; Hassan I; Panayiotidis P; Janossy G; Salmon M; Akbar AN
    Immunology; 1996 Aug; 88(4):508-15. PubMed ID: 8881750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.
    Broome HE; Dargan CM; Krajewski S; Reed JC
    J Immunol; 1995 Sep; 155(5):2311-7. PubMed ID: 7650367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
    Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis.
    Fujii M; Hayashi K; Niki M; Chiba N; Meguro K; Endo K; Kameoka J; Ito S; Abe K; Watanabe T; Satake M
    Oncogene; 1998 Oct; 17(14):1813-20. PubMed ID: 9778047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
    Boudet F; Lecoeur H; Gougeon ML
    J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    Li L; Krajewski S; Reed JC; Choi YS
    Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.
    Hamel ME; Leupers TJ; Kruisbeek AM
    Thymus; 1997; 24(4):259-77. PubMed ID: 9493288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.